Oxford-based Sitryx, which also has operations in Boston in the US, was founded in 2018 with seed funding from SV Health ...

Eli Lilly's oral GLP-1 agonist orforglipron was more effective than Novo Nordisk's recently launched Wegovy pill in a head-to ...

Asahi Kasei has agreed a €780 million (around $920 million) price tag for Wuppertal-based Aicuris, which is hoping for FDA ...

Since 2021, the story of GLP-1s has illustrated that scientific progress is rarely a straight line from hypothesis to patient ...

As Rare Disease Day approaches, in a special episode of the pharmaphorum podcast, sponsored by AOP Health, we spoke with Melissa Fellner, VP of Global Therapeutic Areas, Commercial Operations, at AOP ...

Eisai has a position in kidney cancer with Lenvima (lenvatinib), a kinase inhibitor that is approved for use in combination with MSD's cancer immunotherapy Keytruda (pembrolizumab) as a first-line ...

Who controls the narrative, where the money is going, and why patients need to be at the centre of what comes next News headlines, on your Instagram feed, song lyrics, in day-to-day conversation; few ...

Retention has always been a central concern in long-term studies, but obesity trials present a particular challenge. For those assigned to receive the drug candidate in question, the effects are ...

The manufacturing of GLP-1s involves a complex process that includes peptide synthesis, amino acid coupling, cleavage, purification, and chemical modifications. The solid-phase peptide synthesis (SPPS ...

For Bergstedt, a 33-year-old living with polycystic ovary syndrome (PCOS), the decision to start a GLP-1 medication was not impulsive. She had watched the celebrity before-and-after transformations ...

Pops' decision to step down at the end of July, meanwhile, draws a line under 35 years as CEO of Alkermes, although he will remain chair of the board to help the new CEO, chief operating officer Blair ...

35Pharma's lead development programme is HS235, an activin receptor-targeting fusion protein that has completed phase 1 ...